The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

被引：0
|
作者：
Piotr Rutkowski
Elżbieta Bylina
Anna Klimczak
Tomasz Świtaj
Sławomir Falkowski
Jacek Kroc
Iwona Ługowska
Magdalena Brzeskwiniewicz
Wojciech Melerowicz
Czesław Osuch
Ewa Mierzejewska
Kacper Wasielewski
Agnieszka Woźniak
Urszula Grzesiakowska
Zbigniew I Nowecki
Janusz A Siedlecki
Janusz Limon
机构：
[1] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,Department of Soft Tissue/Bone Sarcoma and Melanoma
[2] Pfizer Poland,Department of Biology and Genetics
[3] Medical University of Gdansk,Department of General Surgery
[4] GreaterPoland Oncological Center,Department of Biostatistics
[5] Jagiellonian University,Laboratory of Experimental Oncology and Department of General Medical Oncology
[6] Medical Faculty,Department of Radiology
[7] Institute of Mother and Child,Department of Gastrointestinal Tumors
[8] KU Leuven and University Hospital,Department of Molecular Biology
[9] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[10] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[11] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
来源：
BMC Cancer | / 12卷
关键词：
Sunitinib; Genotype; GIST; Prognosis; Predictive factors; Arterial hypertension;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [1] The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
    Rutkowski, Piotr
    Bylina, Elzbieta
    Klimczak, Anna
    Switaj, Tomasz
    Falkowski, Slawomir
    Kroc, Jacek
    Lugowska, Iwona
    Brzeskwiniewicz, Magdalena
    Melerowicz, Wojciech
    Osuch, Czeslaw
    Mierzejewska, Ewa
    Wasielewski, Kacper
    Wozniak, Agnieszka
    Grzesiakowska, Urszula
    Nowecki, Zbigniew I.
    Siedlecki, Janusz A.
    Limon, Janusz
    BMC CANCER, 2012, 12
  • [2] Nilotinib in Advanced Gastrointestinal Stromal Tumors after Imatinib and Sunitinib Therapy
    Dizdar, Omer
    Yalcin, Suayib
    HEPATO-GASTROENTEROLOGY, 2011, 58 (112) : 2012 - 2014
  • [3] Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
    Lyseng-Williamson, Katherine A.
    BIODRUGS, 2013, 27 (05) : 525 - 531
  • [4] Regorafenib: A Guide to Its Use in Advanced Gastrointestinal Stromal Tumor (GIST) After Failure of Imatinib and Sunitinib
    Katherine A. Lyseng-Williamson
    BioDrugs, 2013, 27 : 525 - 531
  • [5] A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors ( GIST) following failure of at least imatinib and sunitinib
    Ganjoo, K. N.
    Villalobos, V. M.
    Kamaya, A.
    Fisher, G. A.
    Butrynski, J. E.
    Morgan, J. A.
    Wagner, A. J.
    D'Adamo, D.
    McMillan, A.
    Demetri, G. D.
    George, S.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 236 - 240
  • [6] Phase II study of paclitaxel in patients with advanced gastrointestinal stromal tumor (GIST) after failure of at least both imatinib and sunitinib
    Cho, H.
    Ryu, M-H.
    Kim, B. J.
    Park, Y.
    Na, Y-S.
    Ma, J.
    Beck, M. Y.
    Kang, Y-K.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Impact of Rechallenge with Imatinib in Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib
    Sawaki, Akira
    Kanda, Tatsuo
    Komatsu, Yoshito
    Nishida, Toshirou
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [8] Predictive factors for toxicity and survival of second line sunitinib in advanced gastrointestinal stromal tumours (GIST)
    Den Hollander, D.
    van der Graaf, W. T. A.
    Desar, I. M.
    Mir, O.
    Dumont, S.
    Le Cesne, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] An analysis of arterial hypertension and mutational status as predictive factors for results of sunitinib (SU) therapy in gastrointestinal stromal tumors (GIST).
    Rutkowski, P.
    Bylina, E.
    Switaj, T.
    Klimczak, A.
    Falkowski, S.
    Kroc, J.
    Lugowska, I. A.
    Brzeskwiniewicz, M.
    Wozniak, A.
    Siedlecki, J.
    Limon, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era
    Bonvalot, S.
    Eldweny, H.
    Le Pechoux, C.
    Vanel, D.
    Terrier, P.
    Cavalcanti, A.
    Robert, C.
    Lassau, N.
    Le Cesne, A.
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (12) : 1596 - 1603
12345